// company-profile

Autolus Therapeutics plc

AUTL
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.X0Filings9Insiders9
// api This Autolus Therapeutics plc insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 18 insiders purchased shares. Buying was led by BONNEY MICHAEL W.

// 90-day insight

Over the last 90 days, Autolus Therapeutics plc insiders bought $0 across 18 transactions with no open-market sales.

  • Most active insider: BONNEY MICHAEL W with 2 transactions totaling $0.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Autolus Therapeutics plc as of 2026-03-31

↓ decreasing
Total reported AUM
$183.5M
QoQ change
-15.9%
Reporting period
2026-03-31
#1
MAK CAPITAL ONE LLC
CIK 1385702
$46.4M
33.6M shares
#2
Blackstone Inc.
CIK 1393818
$28.3M
20.5M shares
#3
Syncona Portfolio Ltd
CIK 1725042
$23.0M
16.6M shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 29, 2026BONNEY MICHAEL WAUTL
Award
31,667$0.00$0K
Jun 29, 2026BONNEY MICHAEL WAUTL
Award
47,500$0.00$0K
Jun 29, 2026Azelby RobertAUTL
Award
31,667$0.00$0K
Jun 29, 2026Azelby RobertAUTL
Award
47,500$0.00$0K
Jun 29, 2026Bain LindaAUTL
Award
31,667$0.00$0K

13 more transactions hidden

Free account · No credit card required

Building something? Get API access →